a public good project by the
Synthesis
Company
of California

© 2026

Jacques Bélaïche | doi.page

0 works0 citations0 h-index

Jacques Bélaïche

University of Liège(BE)

Publications by Year

Research Areas

Inflammatory Bowel Disease, Microscopic Colitis, Autoimmune and Inflammatory Disorders, Helicobacter pylori-related gastroenterology studies, Eosinophilic Esophagitis

Most-Cited Works

→ Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease(2001)5,569 cited
→ Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease(2008)2,619 cited
→ CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease(2002)987 cited
→ Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans(1998)568 cited
→ Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4(2007)560 cited
→ Common variants in the NLRP3 region contribute to Crohn's disease susceptibility(2008)516 cited

→ Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.(1994)

434 cited

→ Predictors of severe Crohn's disease(2008)288 cited

→ Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism(2002)242 cited

→ Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease(2002)224 cited